Skip to main content
. 2017 Nov 27;55(12):3544–3551. doi: 10.1128/JCM.01282-17

TABLE 3.

Comparison of HPV-Risk assay and HC2 for HPV detection stratified by clinical outcomea

CIN grade HPV-Risk assay result No. of women with the indicated HC2 result
Total study group
Women ≥30 yr old
Positive Negative Total Positive Negative Total
CIN3+ Positive 78 2 80 62 2 64
Negative 2 0 2 2 0 2
Total 80 2 82 64 2 66
CIN2+ Positive 117 2 119 89 2 91
Negative 5 3 8 5 2 7
Total 122 5 127 94 4 98
≤CIN1 Positive 87 10 97 47 10 57
Negative 33 1,059 1,092 27 906 933
Total 120 1,069 1,189 74 916 990
a

HPV, human papillomavirus; CIN3+, cervical intraepithelial neoplasia grade 3 or worse; CIN2+, cervical intraepithelial neoplasia grade 2 or worse; ≤CIN1, cervical intraepithelial neoplasia grade 1 or lower, i.e., women with two consecutive negative cytology results (control group).